Trial NCT05201183

View at ClinicalTrials.gov 
Org. Study IDs: CTO-IUSCCC-0747

Last trial update was posted on 2023-12-11

MeSH Interventions

Fludarabine

MeSH Conditions

Hematologic Neoplasms Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphocytic Leukemia Acute Myeloid Leukemia Chronic Myeloid Leukemia

Stopping Reasons

insufficient staff and updates in standard practice have made it difficult to recruit participants

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID